The role of protective genetic variants in modulating epigenetic aging
Authors:
Open Access
- 10 February 2025
- journal article
- research article
- Published by Springer Nature in GeroScience
- Vol. 47 (4) , 5995-6004
Abstract
Several progeroid syndromes’ causative mutations have been linked to epigenetic age acceleration as measured via several epigenetic clocks. At the same time, several protective variants have also been discovered that can reduce the risk of developing certain age-related disorders. However, the impact of these protective variants on epigenetic aging has not been well elucidated. Our research, which involved screening over 14,669 healthy individuals enrolled in the Qatar BioBank (QBB) and sequenced by the Qatar Genome Project (QGP), identified individuals carrying protective variants against age-related disorders, including Alzheimer’s disease (AD), type 2 diabetes (T2D), and atherosclerosis. In this study, we measured methylation levels in blood DNA using the EPIC v2 arrays. In addition, epigenetic age was calculated using various epigenetic clocks. Our analysis revealed that the APOE*E2 protective variant reduces the rate of GrimAge epigenetic aging when compared to individuals with the APOE4 AD risk allele. Furthermore, our differential DNA methylation analysis discovered the association of the PCSK9 protective variant with specific biological processes related to immune function and the cardiovascular system. In conclusion, APOE*E2 protective variants have a positive impact on epigenetic aging, while PCSK9 protective variants have a significant effect on DNA methylation signatures. Further studies are needed to better understand the underlying mechanisms by which protective variants influence epigenetic aging, particularly the role of APOE*E2 protective variants in biological aging. Furthermore, additional research is required to fully uncover the processes that might enable specific targeted therapies to mimic the effects of beneficial mutations, such as LOF variants in PCSK9, in reducing the risk of geriatric disorders.Keywords
All Related Versions
Funding Information
- Qatar Foundation
- Qatar Foundation
This publication has 37 references indexed in Scilit:
- Early-onset Alzheimer’s disease due to novel LDLR gene mutationActa Neurologica Belgica, 2023
- DNA methylation clock DNAmFitAge shows regular exercise is associated with slower aging and systemic adaptationGeroScience, 2023
- The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypesNeurobiology of Disease, 2021
- Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive ImpairmentJAMA Neurology, 2021
- Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer’s DiseaseJournal of Molecular Neuroscience, 2020
- A genetic basis for coronary artery diseaseTrends in Cardiovascular Medicine, 2015
- Loss-of-function mutations in SLC30A8 protect against type 2 diabetesNature Genetics, 2014
- Accounting for Population Stratification in DNA Methylation StudiesGenetic Epidemiology, 2014
- Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging RatesMolecular Cell, 2013
- Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's diseaseNeuroscience Letters, 2002